$JSPR

$0.51 -$0.00 (0.9%) Close

$JSPR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 33.3M shares outstanding

Who owns JSPR?

By type of holder

Institutions 36.1% Insiders 0.0% Everyone else 63.9%

Concentration Top 10 holders own 37.8%

Velan Capital Investment Management LP 8.0% · Millennium Management LLC 1.5%

Institutional ownership

36.1%

-11.5 pts vs last qtr

Institutional holders

-13 vs last qtr

Net shares bought

−3.8M

by institutions in Q2 2026

New / sold out

3 / 16

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Gsa Capital Partners LLP +515.6K
Jane Street Group, LLC +80.3K

Biggest sellers in Q2 2026

Morgan Stanley −1.3M
Millennium Management LLC −1.1M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Jasper Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+83.6%

+35.51% a year

Each share's claim on the business

−45.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $18.5M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years67% Under 1 year33%

Quarterly turnover

17.1%

of institutional shares changed hands

Top 10 managers, median time held

2.3 years

Super Investors

Investment managers reporting JSPR on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
VC Velan Capital Investment Management LP	2.7M	8.02%	Unchanged	2024	0.7%
Shares held by quarter Peak holding2.7M (Q3'25) Change over 8 quarters+1.2M Share of the company8.020% Velan Capital Investment Management LP's full portfolio →
MM Millennium Management LLC	486.9K	1.46%	−1.1M (−69.9%)	2025	0.0%
Shares held by quarter Peak holding1.6M (Q1'26) Change over 8 quarters+486.9K Share of the company1.460% Millennium Management LLC's full portfolio →

Velan Capital Investment Management LP

2.7M

% of company

8.02%

Change vs last qtr

Unchanged

Held since

2024

Millennium Management LLC

486.9K

% of company

1.46%

Change vs last qtr

−1.1M (−69.9%)

Held since

2025

28 more super investors behind a free account

See every manager holding Jasper Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting JSPR on Form N-PORT; together they hold 4.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$351K	833.4K	2.50%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$131K	312.0K	0.94%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$351K

% of company

2.50%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$131K

% of company

0.94%

% of the fund

0.00%

As of

June 30, 2026

13 more funds behind a free account

See every fund holding Jasper Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AB Abingworth Bioventures VII LP 5%+ holder 13D · 3.8%	1.1M	3.27%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company3.270% Disclosed stake13D · 3.8% View the 13D/G filing →
AL Abingworth LLP 5%+ holder 13D · 3.8%	1.1M	3.27%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company3.270% Disclosed stake13D · 3.8% View the 13D/G filing →

Abingworth Bioventures VII LP

5%+ holder13D · 3.8%

1.1M

% of company

3.27%

Change vs last qtr

—

Held since

—

Abingworth LLP

5%+ holder13D · 3.8%

1.1M

% of company

3.27%

Change vs last qtr

—

Held since

—

7 more holders behind a free account

See every insider and 5%+ holder of Jasper Therapeutics, Inc..

Comments